LOS ANGELES Physicians and researchers from Cedars-Sinai Medical Center in Los Angeles, will be presenting information on a wide variety of topics at the American College of Cardiologists (ACC) 51st Annual Scientific Session and the ACC Interventional Symposium in Atlanta from March 17 through 20. Topics include acute coronary syndromes, atrial fibrillation, imaging protocols, pregnancy and heart disease, urgent vascular conditions, and clinical trials.

PEPTIDE VACCINE

Cedars-Sinai cardiac researchers, working in collaboration with Swedish investigators, have developed a novel vaccine to prevent plaque buildup in genetically engineered mice with high cholesterol levels. Abstracts of their results are being presented from 3 to 5 p.m. Monday, March 18 at the American College of Cardiologys annual scientific session in Atlanta.

SOY AND ISOFLAVONES FOR PRIMARY PREVENTION (COMPLEMENTARY AND ALTERNATIVE THERAPIES

C. Noel Bairey-Merz, M.D., director of Cedars-Sinais Preventive and Rehabilitative Cardiac Center and director of the Womens Health Program, will discuss Soy and Isoflavones for Primary Prevention during a symposium on Complementary and Alternative Therapies that begins at 10:30 a.m. Tuesday, March 19. In two other Tuesday sessions, she will present information on improving preventive cardiology and treating complex lipid disorders.

HEART DISEASE IN WOMEN

She will also co-chair a symposium on heart disease in women on Wednesday, March 20, beginning at 8:30 a.m.

AZACS STUDY

Bojan Cercek, M.D., will unveil the results of a major clinical trial during the Late-Breaking Clinical Trials I session on Monday, March 18 from 9:15 to 10:30 a.m. This trial tests whether antichlamydial antibiotic therapy with Azithromycin would reduce risk of recurrent heart attack in 1440 high-risk patients. The study was fully funded by the Cedars-Sinai Medical Center Division of Cardiology and a grant t
'"/>

Contact: Sandra Van
sandy@vancommunications.com
1-800-880-2397
Cedars-Sinai Medical Center
15-Mar-2002